Issued Patents All Time
Showing 26–50 of 132 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11471487 | Compositions and methods of stimulating and expanding T cells | Yangbing Zhao, Xiaojun Liu | 2022-10-18 |
| 11459390 | Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptor | Jennifer Brogdon, Hilmar Erhard Ebersbach, David Glass, Thomas Huber, Julia Jascur +11 more | 2022-10-04 |
| 11407805 | Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof | Saar Gill, Michael Klichinsky | 2022-08-09 |
| 11359002 | Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof | Saar Gill, Michael Klichinsky | 2022-06-14 |
| 11332511 | Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof | Saar Gill, Michael Klichinsky | 2022-05-17 |
| 11325963 | Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof | Saar Gill, Michael Klichinsky | 2022-05-10 |
| 11319358 | Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof | Saar Gill, Michael Klichinsky | 2022-05-03 |
| 11306134 | Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof | Saar Gill, Michael Klichinsky | 2022-04-19 |
| 11306133 | Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof | Saar Gill, Michael Klichinsky | 2022-04-19 |
| 11299536 | Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer | Matthew J. Frigault, Yangbing Zhao, John Scholler | 2022-04-12 |
| 11274298 | RNA engineered T cells for the treatment of cancer | Yangbing Zhao | 2022-03-15 |
| 11273219 | Toxicity management for anti-tumor activity of CARs | Bruce L. Levine, Michael D. Kalos, Stephan Grupp | 2022-03-15 |
| 11208661 | Altering gene expression in modified T cells and uses thereof | Yangbing Zhao, Jiangtao Ren, Xiaojun Liu | 2021-12-28 |
| 11203758 | Altering gene expression in modified T cells and uses thereof | Yangbing Zhao, Jiangtao Ren, Xiaojun Liu | 2021-12-21 |
| 11161907 | Car-expressing cells against multiple tumor antigens and uses thereof | Daniel J. Powell, Jr. | 2021-11-02 |
| 11149076 | CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell | Hans Bitter, Jennifer Bordeaux, Barbara Brannetti, Jennifer Brogdon, Naveen Dakappagari +12 more | 2021-10-19 |
| 11090336 | Tn-MUC1 chimeric antigen receptor (CAR) T cell therapy | Avery D. Posey | 2021-08-17 |
| 11084880 | Anti-BCMA chimeric antigen receptor | Jennifer Brogdon, Eugene Choi, Hilmar Erhard Ebersbach, David Glass, Heather Huet +9 more | 2021-08-10 |
| 11034749 | Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof | Saar Gill, Michael Klichinsky | 2021-06-15 |
| 11028177 | Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells | Jennifer Brogdon, Saar Gill, Michael D. Kalos, Andreas Loew, John Scholler | 2021-06-08 |
| 11028143 | Enhanced antigen presenting ability of RNA CAR T cells by co-introduction of costimulatory molecules | Yangbing Zhao, Devon Shedlock, Xiaojun Liu | 2021-06-08 |
| 11001805 | ICOS critically regulates the expansion and function of inflammatory human Th17 cells | James L. Riley, Chrystal Paulos, Bruce L. Levine | 2021-05-11 |
| 10981969 | Switch costimulatory receptors | Yangbing Zhao | 2021-04-20 |
| 10927184 | Treatment of cancer using humanized anti-CD19 chimeric antigen receptor | Jennifer Brogdon, Andreas Loew, Marcela Maus, John Scholler | 2021-02-23 |
| 10874727 | Inducible regulatory t-cell generation for hematopoietic transplants | James L. Riley, Bruce R. Blazar, Keli Hippen | 2020-12-29 |